I'm not trying to be negative or bash, but there is absolutely some history with this epi-pen that didn't go as planned. I found this news announcement from July 2009, couple months after coming public via reverse merger. They predicated profitability in 12 months. That didn't happen obviously and they never sold any of these. That's where my comments about something stopping this come from. Not really important what happened almost 6 years ago as the company is in much better shape now and I want approval like any other long. but it relates to the question asked.
I made reference to this in another post last week. I don't claim to have 100% of the exact details but it was absolutley longer than 18 months ago. I have been following (buying & selling ADMP) since becoming public via the reverse merger from Cellegy (more than 4 years ago I think). I don't know hardly anything about Cellegy's history (Wyatt, Brokerbuzz and Startruxx are better informed there I think). My recollection is that from inception the plan was to get this marketed to drive revenue for other projects. Either big pharma bullied FDA into saying there was a problem with filing or there just was and not enough cash to fix it. So survival mode from that point on. As others have said, news and finance deals are indicating the future looks very bright right now. I don't post a lot but I read most of the messages and like many am hoping this company can achieve some of the price levels mentioned by others. Good luck with your investments.
I think he is just illustrating a "could happen" scenario, that it happened to another company maybe it will happen to ADMP. I saw the same headline on Yahoo Finance but didn't read the article. Anything is possible in the markets if somebody with deep pockets thinks theirs value they will simply just buy the whole thing when a company is so small. I don't know that they actually paid $7m for their prostrate cancer drugs (Inhaler yes). They got exclusive rights for them from Univ Wisconsin, but I don't recall seeing any $$ details. That was 3 years or so ago I think.
Wyatt, something happened with this the same year after they did reverse merger to become Adamis. I don't know the details of submission or otherwise, but I recall that supposedly distribution deals were in place with stores like Walgreens and maybe others. Does that sound familiar? Someone then posted sometype of letter from FDA saying there was either a problem with the filing or product and it was a dead issue until new funding in 2013. Don't know if that counts as the first submission or it was some other type of request. Point is that this might be their 2nd attempt. I'm hoping for the best like the rest as I averaged back in after the drop at around $4.80.